News
Structure Therapeutics Inc. (NASDAQ:GPCR) showcased preclinical findings for ACCG-2671 and GSBR-5595 in two late-breaking posters at the ADA 85th Scientific Sessions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback